Insider Transactions in Q1 2022 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2022
|
Kevin Rakin Director |
SELL
Open market or private sale
|
Direct |
10,000
-17.65%
|
$90,000
$9.41 P/Share
|
|
Feb 17
2022
|
Kevin Rakin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,010
-5.04%
|
$30,100
$10.63 P/Share
|
|
Feb 17
2022
|
Kevin Rakin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+10.05%
|
$26,668
$4.8 P/Share
|
|
Feb 11
2022
|
Kevin Rakin Director |
SELL
Bona fide gift
|
Direct |
5,000
-9.61%
|
-
|
|
Jan 09
2022
|
Netanel Derovan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+50.0%
|
-
|
|
Jan 03
2022
|
Aviad Friedman Director |
SELL
Bona fide gift
|
Direct |
6,000
-100.0%
|
-
|
|
Jan 03
2022
|
Aviad Friedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+50.0%
|
-
|
|
Jan 03
2022
|
David Silberman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+21.59%
|
-
|
|
Jan 03
2022
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+14.45%
|
-
|
|
Jan 03
2022
|
Kevin Rakin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+9.37%
|
-
|
|
Jan 03
2022
|
Michael Rabinowitz Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+14.79%
|
-
|
|
Jan 03
2022
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+18.61%
|
-
|
|
Jan 03
2022
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
213,000
+10.01%
|
-
|
|
Jan 03
2022
|
Nadav Kidron President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
48,752
-5.21%
|
$633,776
$13.89 P/Share
|
|
Jan 03
2022
|
Arie Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+40.0%
|
-
|
|
Jan 03
2022
|
Leonard Sank Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+50.0%
|
-
|